SOURCE-LINKED INTELLIGENCE
MONITOR RESPIRATORY HEALTH USING VOICE
lly evaluate patients without using any digital solution, leading to a 50% rate in non-well-controlled patients. Deep-tech innovation: VoiceMed uses vocal biomarkers combined with sound analysis and artificial intelligence. Our technology detects subtle signals in the sounds produced by the vocal apparatus. When the association between a signal either a normal biological or pathogenic state is fully validated, these signals become vocal biomarkers. This process allows going beyond the sounds routinely used in medical practice, such as wheezes or crackles, and unlocking a new dimension of biomarkers that can be assessed remotely, instantaneously and with no extra equipment. Women Founders: Arianna Arienzo (CEO) - +6 years experience in business in 5 countries (including Silicon Valley). Entrepreneur in digital health and digital technologies. Listed in Forbes Under 30 in 2022. Contract professor at Cattolica university in healthcare innovation. Msc business administration. Dr. Ayana de Brito (CSO) - +9 years’ experience as a research scientist in computational biology, currently lea
Read original source ↗ Open in workspace
- recordType
- award
- status
- CLOSED
- region
- EU
- value
- 75000
- unit
- EUR
Evidence & attribution
European Commission, CORDIS Horizon Europe project dataset. Metadata adapted.
License: CORDIS reuse policy
First collected: 2026-09-20T01:21:06.728Z. This is not the publication date.